Skip to main content
logo
Kane Biotech Inc. (TSXV:KNE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0300
+0.0050 (20.00%)
Aug 28, 2026, 2:46 PM EST

Kane Biotech Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6715111118
Market Cap Growth
-7.28%-51.98%43.41%-6.12%-36.87%17.03%
Enterprise Value
7917201923
Last Close Price
0.030.040.110.080.090.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--2.48---
PS Ratio
158.9916.987.2770.8071.6811.07
PB Ratio
-6.19-9.73-9.28-1.25-2.71-11.36

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
187.6220.158.11136.29121.7714.60

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.97-3.09-1.33-1.10-1.66-3.01
Net Debt / Equity Ratio
-1.11-1.88-1.11-1.01-1.39-2.28
Net Debt / EBITDA Ratio
-0.42-0.55-0.50-2.63-1.75-0.75
Net Debt / FCF Ratio
-0.44-0.43-0.44-4.07-1.89-1.44
Asset Turnover
0.010.160.510.030.030.29
Inventory Turnover
0.100.973.860.080.072.10
Quick Ratio
0.350.380.190.080.340.47
Current Ratio
0.610.680.430.340.490.61
Return on Assets (ROA)
-54.45%-62.39%-56.84%-37.06%-36.77%-53.91%
Return on Capital Employed (ROCE)
788.70%-1123.90%-4414.80%64.30%479.10%-340.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-43.90%-37.46%40.31%-47.73%-34.62%-25.87%
FCF Yield
-40.59%-44.88%-27.34%-19.83%-27.17%-13.91%
Buyback Yield / Dilution
-10.32%-4.40%-22.23%-5.32%-7.20%-3.67%